Logo

Drug Discovery & Development

News on drug screening, clinical trials, companion diagnostics, immunotherapy, & personalized therapies in genetics, genomics, and molecular diagnostics.

Jan 24, 2023

ImmPact Bio to Begin Phase I/II Trial of Bispecific CAR T-Cell Therapy in Aggressive Lymphoma

Jan 23, 2023

Viewpoint Molecular Targeting Treats First Neuroendocrine Cancer Patients With Radiopharmaceutical

Jan 20, 2023

Astellas' Zolbetuximab Plus Chemo Benefits CLDN18.2-Positive, HER2-Negative Gastric Cancer Patients
Premium

Jan 20, 2023

Mirati Therapeutics' KRAS G12D Inhibitor Cleared by FDA to Begin Phase I/II Trial

Jan 19, 2023

NeoPhore Raises $28.5M in Series B Financing

Jan 18, 2023

Penn Scientists Testing Out CAR T-Cell Therapy Gel to Prevent Breast Cancer Recurrence Post-Surgery
Premium

Jan 17, 2023

Yantai LNC Biotechnology to Use Sofie Biosciences Imaging Agent to ID Patients for Theranostic Trial

Jan 17, 2023

Leap Therapeutics Merges With Flame Biosciences to Advance Several Precision Oncology Drugs

Jan 17, 2023

Elicio Therapeutics to Merge With Angion Biomedica

Jan 17, 2023

Lantern Pharma Preparing IND for Synthetic Lethality Program With FDA Feedback

Jan 13, 2023

JP Morgan Healthcare Conference, Day 4: Elevation Oncology, Zymeworks, Achilles Therapeutics

Jan 12, 2023

EQRx Focuses Pipeline Strategy After Disappointing FDA Feedback on PD-L1 Inhibitor

Jan 12, 2023

JP Morgan Healthcare Conference, Day 3: Iovance Biotherapeutics, Biomea Fusion, ADC Therapeutics

Jan 11, 2023

Bio4t2 Begins Dosing Solid Tumor Patients in First-In-Human CAR T-Cell Therapy Trial

Jan 11, 2023

JP Morgan Healthcare Conference, Day 2: Roche, Zai Lab, Revolution Medicines, Ideaya Biosciences

Jan 10, 2023

Immunocore Unveils New T-Cell Receptor Therapy Candidates, Estimates $140M in 2022 Kimmtrak Sales

Jan 10, 2023

NextPoint Therapeutics Raises $80M in Series B Financing

Jan 9, 2023

Aethon Therapeutics Launches With $30M in Series A Funding to Tackle Cancer Therapy Resistance

Jan 9, 2023

Genentech Offers Kronos Bio up to $554M in Deal to Discover Drugs Against Transcription Factors

Jan 9, 2023

GreenLight Biosciences, EpiVax Therapeutics Partner to Develop Personalized Cancer Vaccines